APIs, or Active Pharmaceutical Ingredients, are the components in a pharmaceutical drug that produce the intended therapeutic effect. Our portfolio spans 55 commercial APIs manufactured under stringent quality systems for global pharmaceutical companies.

Pharmaceutical intermediates serve as building blocks used during API production. They are used solely in the synthesis of APIs and are not directly administered to patients.

Pellets are small, free-flowing, spherical particles made by combining fine powders or granules of drugs and excipients — value-added, semi-finished formulations for novel drug delivery systems.

Piperidines are among the most important synthetic fragments for designing drugs and play a significant role in the pharmaceutical industry. Cost-effective processes for these derivatives are our core expertise.

Under-development APIs are driven by pharmaceutical innovation, enabling us to meet dynamic healthcare demands and emerging treatment challenges.

VPCL offers long-term contract manufacturing services — from strategic partnerships in development and validations to DMF filing and commercial manufacturing.